Author:
Zhang Mengyuan,He Jianhua,Zhang Wenli,Liu Jianping
Funder
National Natural Science Foundation of China
Jiangsu Province Ordinary College and University Innovative Research Programs
Priority Academic Program Development of Jiangsu Higher Education Institutions
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference37 articles.
1. Duivenvoorden R, Tang J, Cormode DP, Mieszawska AJ, Izquierdogarcia D, Ozcan C, et al. A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation. Nat Commun. 2014;5(2):1661–7.
2. Yang H, Tyagi P, Kadam RS, Holden CA, Kompella UB. Hybrid dendrimer hydrogel/PLGA nanoparticle platform sustains drug delivery for one week and antiglaucoma effects for four days following one-time topical administration. ACS Nano. 2012;6(9):7595–606.
3. Hadinoto K, Sundaresan A, Cheow WS. Lipid–polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Eur J Pharm Biopharm. 2013;85(3):427–43.
4. Tan SW, Li X, Guo YJ, Zhang ZP. Lipid-enveloped hybrid nanoparticles for drug delivery. Nanoscale. 2013;5(3):860–72.
5. Hu Y, Zhao Z, Ehrich M, Fuhrman K, Zhang C. In vitro controlled release of antigen in dendritic cells using pH-sensitive liposome-polymeric hybrid nanoparticles. Polymer. 2015;80:171–9.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献